Chief Financial Officer
James Fair has over ten years’ experience working in the bioscience sector. A mathematics graduate, James qualified as a chartered accountant in 1992 having trained with a Big Four firm. He has been head of finance with Fusion Antibodies for 8 years on a secondment basis and joined the Company as a Director full time on 1 August 2017, where he is responsible for all aspects of financial management including internal and external financial reporting. He has been involved in the growth of the business and previous raisings for the Company.
James’s previous experience has included senior management positions in internal audit, business and professional practice where his recent experience was in advising and supporting start-up and spin out companies from Northern Ireland entrepreneurs and local Universities.